Surprise Inspection by Vidisha Collector & SP Exposes Sale of Banned Drugs

Nov 23, 2024

Pharmacy Inspections & Drug Safety, Regulatory Updates, State-Specific Healthcare News
Pharmacy Inspections & Drug Safety, Regulatory Updates, State-Specific Healthcare News

Share:

In an unexpected move that sent shockwaves through the local medical community, Vidisha Collector Roshan Kumar Singh and SP Rohit Kashwani conducted surprise inspections at several medical stores near the city’s hospital on Saturday.
During the inspections, they scrutinized drug stocks, purchase and sale records, and compliance with regulations on restricted and prescription drugs. At Balaji Shri Medical Store, restricted medicines such as Codilex-T (100 ml) were discovered.What Went Wrong?
The store owner failed to provide:

  • Purchase bills

  • Prescription records

  • Stock registers

This raised red flags regarding the sale of restricted drugs. The authorities immediately documented the violations, and Drug Inspector Yogesh Tiwari initiated action on the spot.Key Takeaways from the Inspection

  1. Crackdown on Non-Compliance: The inspection highlighted issues of non-compliance with drug laws, such as selling restricted medications without proper documentation.

  2. Accountability Measures: Authorities are pushing for stricter adherence to protocols, emphasizing the importance of maintaining purchase records and prescriptions for restricted drugs.

  3. Immediate Action: The Drug Inspector filed a formal report (Panchanama), and legal action is being pursued against the violators.

Why This Matters to Pharmacists

  • Compliance Is Critical: Ensure all restricted and prescription medicines are backed by valid documentation to avoid penalties.

  • Frequent Inspections: With increasing regulatory scrutiny, maintaining accurate stock and transaction records is no longer optional.

  • Reputation at Risk: Such incidents can tarnish the reputation of a pharmacy, emphasizing the need for diligence and compliance.

Pharmacy Inspections & Drug Safety
Regulatory Updates
State-Specific Healthcare News
Pharmacy Inspections & Drug Safety
Regulatory Updates
State-Specific Healthcare News

Surprise Inspection by Vidisha Collector & SP Exposes Sale of Banned Drugs

Nov 23, 2024

Pharmacy Inspections & Drug Safety, Regulatory Updates, State-Specific Healthcare News
Pharmacy Inspections & Drug Safety, Regulatory Updates, State-Specific Healthcare News

In an unexpected move that sent shockwaves through the local medical community, Vidisha Collector Roshan Kumar Singh and SP Rohit Kashwani conducted surprise inspections at several medical stores near the city’s hospital on Saturday.
During the inspections, they scrutinized drug stocks, purchase and sale records, and compliance with regulations on restricted and prescription drugs. At Balaji Shri Medical Store, restricted medicines such as Codilex-T (100 ml) were discovered.What Went Wrong?
The store owner failed to provide:

  • Purchase bills

  • Prescription records

  • Stock registers

This raised red flags regarding the sale of restricted drugs. The authorities immediately documented the violations, and Drug Inspector Yogesh Tiwari initiated action on the spot.Key Takeaways from the Inspection

  1. Crackdown on Non-Compliance: The inspection highlighted issues of non-compliance with drug laws, such as selling restricted medications without proper documentation.

  2. Accountability Measures: Authorities are pushing for stricter adherence to protocols, emphasizing the importance of maintaining purchase records and prescriptions for restricted drugs.

  3. Immediate Action: The Drug Inspector filed a formal report (Panchanama), and legal action is being pursued against the violators.

Why This Matters to Pharmacists

  • Compliance Is Critical: Ensure all restricted and prescription medicines are backed by valid documentation to avoid penalties.

  • Frequent Inspections: With increasing regulatory scrutiny, maintaining accurate stock and transaction records is no longer optional.

  • Reputation at Risk: Such incidents can tarnish the reputation of a pharmacy, emphasizing the need for diligence and compliance.

Share:

Pharmacy Inspections & Drug Safety
Regulatory Updates
State-Specific Healthcare News
Pharmacy Inspections & Drug Safety
Regulatory Updates
State-Specific Healthcare News